Share-based Compensation (Tables)
|
12 Months Ended |
Dec. 31, 2021 |
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] |
|
Summary of the Share Options Activities |
A summary of the share options activities for years ended December 31, 2019, 2020 and 2021:
|
|
|
|
|
|
Weighted
|
|
|
Weighted
|
|
Aggregate
|
|
|
|
|
|
|
average
|
|
|
remaining
|
|
Intrinsic
|
|
|
Number of
|
|
|
exercise
|
|
|
contractual
|
|
Value
|
|
|
shares
|
|
|
USD
|
|
|
years
|
|
USD
|
Outstanding as of December 31, 2018
|
|
|
1,142,212
|
|
|
|
0.67
|
|
|
|
|
|
Granted
|
|
|
70,000
|
|
|
|
0.50
|
|
|
|
|
|
Exercised
|
|
|
—
|
|
|
|
—
|
|
|
|
|
|
Forfeited
|
|
|
(809,712)
|
|
|
|
0.61
|
|
|
|
|
|
Cancelled
|
|
|
—
|
|
|
|
—
|
|
|
|
|
|
Expired
|
|
|
—
|
|
|
|
—
|
|
|
|
|
|
Outstanding as of December 31, 2019
|
|
|
402,500
|
|
|
|
0.75
|
|
|
|
|
|
Granted
|
|
|
424,698
|
|
|
|
1.26
|
|
|
|
|
|
Exercised
|
|
|
—
|
|
|
|
—
|
|
|
|
|
|
Forfeited
|
|
|
—
|
|
|
|
—
|
|
|
|
|
|
Cancelled
|
|
|
—
|
|
|
|
—
|
|
|
|
|
|
Expired
|
|
|
—
|
|
|
|
—
|
|
|
|
|
|
Outstanding as of December 31, 2020
|
|
|
827,198
|
|
|
|
1.01
|
|
|
|
|
|
Granted
|
|
|
181,750
|
|
|
|
0.57
|
|
|
|
|
|
Exercised
|
|
|
(62,416)
|
|
|
|
0.58
|
|
|
|
|
|
Forfeited
|
|
|
(135,700)
|
|
|
|
0.57
|
|
|
|
|
|
Cancelled
|
|
|
—
|
|
|
|
—
|
|
|
|
|
|
Expired
|
|
|
—
|
|
|
|
—
|
|
|
|
|
|
Outstanding as of December 31, 2021
|
|
|
810,832
|
|
|
|
1.02
|
|
|
|
|
|
Vested and expected to vest as of December 31, 2021
|
|
|
810,832
|
|
|
|
1.02
|
|
|
7.23
|
|
58
|
Exercisable as of December 31, 2021
|
|
|
260,500
|
|
|
|
0.85
|
|
|
6.44
|
|
38
|
|
Schedule of Information Relating to Options Outstanding and Exercisable |
Information relating to options outstanding and exercisable as of December 31, 2021 is as follows:
Options outstanding as of December 31, 2021
|
|
Options exercisable as of December 31, 2021
|
|
|
Exercise
|
|
Remaining
|
|
|
|
Exercise
|
|
Remaining
|
Number of
|
|
Price
|
|
Contractual
|
|
Number
|
|
Price
|
|
Contractual
|
Shares
|
|
per Share
|
|
Life
|
|
of Shares
|
|
per Share
|
|
Life
|
|
|
USD
|
|
Years
|
|
|
|
USD
|
|
Years
|
62,500
|
|
1.71
|
|
5.05
|
|
62,500
|
|
1.71
|
|
5.05
|
259,584
|
|
0.58
|
|
6.85
|
|
186,250
|
|
0.58
|
|
6.85
|
18,000
|
|
0.53
|
|
7.21
|
|
11,750
|
|
0.53
|
|
7.21
|
424,698
|
|
1.26
|
|
7.60
|
|
—
|
|
—
|
|
—
|
46,050
|
|
0.57
|
|
9.01
|
|
—
|
|
—
|
|
—
|
810,832
|
|
1.02
|
|
7.23
|
|
260,500
|
|
0.85
|
|
6.44
|
|
Summary of Assumptions Used in the Valuation Model |
The Company calculated the fair value of the share options on the grant date, for the years ended December 31, 2019, 2020 and 2021, using the Black-Scholes-Merton pricing valuation model. The assumptions used in the valuation model are summarized as follows:
|
|
Year Ended December 31,
|
|
|
2019
|
|
2020
|
|
2021
|
Expected dividend yield
|
|
0%
|
|
0%
|
|
0%
|
Expected volatility
|
|
55%/54%
|
|
57%
|
|
70%
|
Expected term
|
|
6.08
|
|
6.04
|
|
5.40
|
Risk-free interest rate (per annum)
|
|
2.53%/2.45%
|
|
0.67%
|
|
0.90%
|
|
Options |
|
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] |
|
Schedule of Compensation Expense Recognized for Non-vested Shares |
Compensation expense recognized for non-vested share options for the year ended December 31, 2019, 2020 and 2021 is allocated to the following expense items:
|
|
Year Ended December 31,
|
|
|
2019
|
|
|
2020
|
|
|
2021
|
|
|
RMB
|
|
|
RMB
|
|
|
RMB
|
Cost of revenues
|
|
—
|
|
|
—
|
|
|
62,224
|
Research and development
|
|
68,016
|
|
|
—
|
|
|
6,944
|
Sales and marketing
|
|
—
|
|
|
—
|
|
|
6,806
|
General and administrative
|
|
345,991
|
|
|
316,815
|
|
|
476,435
|
Total share-based compensation expense
|
|
414,007
|
|
|
316,815
|
|
|
552,409
|
|
Non-vested shares |
|
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] |
|
Schedule of Compensation Expense Recognized for Non-vested Shares |
Compensation expense recognized for non-vested shares for the years ended December 31, 2019, 2020 and 2021 is allocated to the following expense items:
|
|
Year Ended December 31,
|
|
|
2019
|
|
|
2020
|
|
|
2021
|
|
|
RMB
|
|
|
RMB
|
|
|
RMB
|
Cost of revenues
|
|
|
—
|
|
|
|
—
|
|
|
27,806
|
Research and development
|
|
|
367,313
|
|
|
|
74,861
|
|
|
3,692
|
Sales and marketing
|
|
|
—
|
|
|
|
—
|
|
|
11,741
|
General and administrative
|
|
|
4,028,134
|
|
|
|
1,385,107
|
|
|
444,324
|
Total share-based compensation expense
|
|
|
4,395,447
|
|
|
|
1,459,968
|
|
|
487,563
|
|
Summary of the Non-vested Shares Activities |
A summary of the non-vested shares activities for the year ended December 31, 2019, 2020 and 2021 is presented below:
|
|
|
|
|
|
Weighted average
|
|
|
|
Number
|
|
|
grant date
|
|
|
|
of shares
|
|
|
fair value
|
|
|
|
|
|
|
|
USD
|
|
Outstanding at December 31, 2018
|
|
|
1,795,498
|
|
|
|
0.951
|
|
Granted
|
|
|
—
|
|
|
|
—
|
|
Vested
|
|
|
(693,362)
|
|
|
|
0.885
|
|
Forfeited
|
|
|
—
|
|
|
|
—
|
|
Cancelled
|
|
|
—
|
|
|
|
—
|
|
Outstanding at December 31, 2019
|
|
|
1,102,136
|
|
|
|
0.933
|
|
Granted
|
|
|
—
|
|
|
|
—
|
|
Vested
|
|
|
(484,678)
|
|
|
|
1.043
|
|
Forfeited
|
|
|
(14,370)
|
|
|
|
0.907
|
|
Cancelled
|
|
|
—
|
|
|
|
—
|
|
Outstanding at December 31, 2020
|
|
|
603,088
|
|
|
|
0.955
|
|
Granted
|
|
|
77,500
|
|
|
|
1.545
|
|
Vested
|
|
|
(419,752)
|
|
|
|
1.112
|
|
Forfeited
|
|
|
(61,500)
|
|
|
|
1.545
|
|
Cancelled
|
|
|
—
|
|
|
|
—
|
|
Outstanding at December 31, 2021
|
|
|
199,336
|
|
|
|
0.671
|
|
|